Project Details
Description
Allogeneic Natural Killer Cells with Rituximab in Patients with CD20 Positive Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/08 → 3/30/12 |
Funding
- CLL TOPICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.